In the absence of a validated prognostic score, pediatric treatment regimens have historically classified patients as low-, intermediate-, or high-risk on the basis of a combination of stage, the ...
Delayed treatment escalation, initial antibiotic therapy use, and timing differences in therapy initiation were noted in pediatric patients with HS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results